PDB61 COMPARE LIXISENATIDE WITH RAPID-ACTING INSULIN INTENSIFICATION REGIMENS ON TOP OF BASAL INSULIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A COST PER RESPONDER AND NUMBER NEEDED TO TREAT ANALYSIS IN CHINA
May 1, 2019, 00:00
10.1016/j.jval.2019.04.610
https://www.valueinhealthjournal.com/article/S1098-3015(19)30802-2/fulltext
Title :
PDB61 COMPARE LIXISENATIDE WITH RAPID-ACTING INSULIN INTENSIFICATION REGIMENS ON TOP OF BASAL INSULIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A COST PER RESPONDER AND NUMBER NEEDED TO TREAT ANALYSIS IN CHINA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)30802-2&doi=10.1016/j.jval.2019.04.610
First page :
Section Title :
Open access? :
No
Section Order :
10230